{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:22:12Z","timestamp":1760782932390},"reference-count":13,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000},"content-version":"vor","delay-in-days":10061,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[1979,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Factors influencing survival were reviewed in 464 patients with recurrent breast cancer. Site of first recurrence and rate of tumor progression governed prognosis more than choice of initial therapy. Overall median survival was 22\u201426 months for bone\/soft\u2010tissue disease, 10\u201412 months for pleura\/lung, and 4\u20146 months for liver\/brain recurrence. Patients with slow rates of tumor progression at each site had longer survival terms than did rapid progressors. About 50% of patients with bone or soft\u2010tissue recurrence had slow progression and long survival, regardless of whether initial treatment was local or systemic. In visceral recurrence, the number of patients with slow progression was doubled with systemic therapy in comparison to local treatment (from 16\u201420% for the latter to 37\u201438% for the former). In addition, long\u2010term survival in patients with similar progression rates was best using initial systemic therapy.<\/jats:p>","DOI":"10.1002\/jso.2930110106","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T04:47:24Z","timestamp":1171946844000},"page":"21-29","source":"Crossref","is-referenced-by-count":16,"title":["Recurrent breast cancer: Factors influencing survival, including treatment"],"prefix":"10.1002","volume":"11","author":[{"given":"N. W.","family":"Pearlman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. R.","family":"Jochimsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197708182970704"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-84-4-389"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(58)90126-7"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196911)24:5<861::AID-CNCR2820240502>3.0.CO;2-3"},{"key":"e_1_2_1_6_1","first-page":"1039","article-title":"Advanced Breast Carcinoma\u2010Factors Influencing Survival","volume":"19","author":"Escher GC","year":"1963","journal-title":"Acta Unio Int Cancrum"},{"key":"e_1_2_1_7_1","first-page":"232","article-title":"Response of Patients With Carcinoma of The Breast To Hormonal Therapy and Combination Chemotherapy","volume":"141","author":"Henderson MD","year":"1975","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(73)80057-1"},{"key":"e_1_2_1_9_1","first-page":"525","article-title":"Prognostic Value of Estrogen Receptor to Endocrine Ablation in Cancer of The Breast","volume":"139","author":"Leung BS","year":"1974","journal-title":"Surg Cynecol Obstet"},{"key":"e_1_2_1_10_1","first-page":"376","article-title":"Adrenalectomy With Chemotherapy In The Treatment Of Advanced Breast Cancer: Objective And Subjective Response Rates; Duration And Quality Of Life","volume":"76","author":"Moore FD","year":"1974","journal-title":"Surgery"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197601000-00017"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195401)7:1<29::AID-CNCR2820070105>3.0.CO;2-2"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197702)39:2<547::AID-CNCR2820390225>3.0.CO;2-9"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-84-4-389"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.2930110106","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.2930110106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T04:58:17Z","timestamp":1699851497000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.2930110106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1979,1]]}},"alternative-id":["10.1002\/jso.2930110106"],"URL":"https:\/\/doi.org\/10.1002\/jso.2930110106","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"value":"0022-4790","type":"print"},{"value":"1096-9098","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979,1]]}}}